Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
96 Leser
Artikel bewerten:
(0)

Global Gene Expression Market 2015-2019: Key Vendors are Affymetrix, Agilent Technologies, Bio-Rad Laboratories, F. Hoffmann-La Roche, Illumina, Qiagen and Thermo Fisher Scientific

DUBLIN, Jan. 29, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/qwfqn4/global_gene) has announced the addition of the "Global Gene Expression Market 2015-2019" report to their offering.

600769

Gene expression is the biological process where genetic information is used for the synthesis of a functional gene product, either RNA or protein. Gene expression products allow researchers to study gene expression and its impact on cell function. Researchers use gene expression profiling and analysis for various applications in the areas of drug discovery and development, clinical diagnostics, and other research purposes. Advanced PCR, NGS, and DNA microarray technology allow profiling and analysis of thousands of genes in a very short period with great accuracy and reproducibility.

The analysts forecast the Global Gene Expression market to grow at a CAGR of 11.12 percent over the period 2014-2019.

This report covers the present scenario and the growth prospects of the Global Gene Expression market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of gene expression products including consumables, instruments, and services. It has a wide range of applications in various fields such as

  • Drug discovery and development
  • Clinical diagnostics
  • Research
  • Others

One of the major trends upcoming in this market is the automation of gene expression profiling. This helps reduce consumption of reagents, and enhances accuracy and productivity in research and drug discovery.

According to the report, one of the major drivers of the market is advances in gene expression technology. As a result of automation, accuracy, and sensitivity of gene expression, technology and products have improved. Advanced gene expression products such as DNA microarray chips, RT-PCR, and advanced NGS provide a high degree of accuracy, efficiency, and productivity in research and drug discovery.

Further, the report states that one of the major challenges in the market is intense competition among vendors. Numerous large and medium-scale companies in the market provide high-end gene expression products, including instruments and software.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Application

08. Market Segmentation by Technology

09. Market Segmentation by Product Type

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

20. Other Reports in this Series

Companies Mentioned:

  • Affymetrix
  • Agena Bioscience
  • Agilent Technologies
  • Applied Microarrays
  • Arrayit
  • AutoGenomics
  • BD
  • Beijing Genomics Institute
  • Bio-Rad Laboratories
  • BioChain Institute
  • Biometrix Technology
  • Cepheid
  • CombiMatrix
  • Danaher
  • Danyel Biotech (a Part of Gamida for Life Group)
  • EMD Millipore
  • Eppendorf
  • Exiqon
  • F. Hoffmann-La Roche
  • Fluidigm
  • GE Healthcare
  • Great Basin
  • Illumina
  • LC Sciences
  • Luminex
  • Microarrays
  • Miltenyi Biotec
  • OriGene Technologies
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Partek
  • Perkin Elmer
  • Phalanx Biotech Group
  • Promega
  • Qiagen
  • Takara Bio
  • Tecan
  • Thermo Fisher Scientific
  • Veredus Laboratories
  • Zyagen

For more information visit http://www.researchandmarkets.com/research/qwfqn4/global_gene

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.